3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Head & Neck
2
Conditions
Breast Neoplasms
11
Prostatic Neoplasms
6
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Liver Neoplasms
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Liver Cirrhosis
2
Kidney Neoplasms
2
Carcinoma, Hepatocellular
2
Brain Neoplasms
2
Urologic Neoplasms
1
Urethral Neoplasms
1
Thoracic Neoplasms
1
Testicular Neoplasms
1
Solid Tumor
1
Renal Colic
1
Rectal Neoplasms
1
Pregnancy, Ectopic
1
Pneumonia
1
Pleural Effusion
1
Phlebitis
1
Penile Neoplasms
1
Mesothelioma
1
Melanoma
1
Margins of Excision
1
Lymphoma, Primary Effusion
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Paclitaxel
11
Carboplatin
11
Fluorouracil
10
Biopsy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Drug Therapy
9
Taxes
7
Surgical Procedures, Operative
7
Celecoxib
7
X-Rays
6
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Surveys and Questionnaires
5
Nivolumab
5
cemiplimab
4
Metformin
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Chemoradiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Mouth Neoplasms
×
Ultrasonography
×
Clear all
NCT07203911
2026-05-13
SURGIO
Rigshospitalet, Denmark
Phase NA
Recruiting
150 enrolled
NCT06336941
2026-02-25
HOUSTON
University of Pisa
Phase NA
Recruiting
400 enrolled